Researchers at Boston-based Harvard Medical School and University of Oxford in England have created an AI tool to forecast which COVID-19 strains will grow in dominance, according to an Oct. 11 article in Nature.
Teresa Johnson has been in extreme pain for more than a year after what she believes was a severe allergic reaction to iodine. Her Medi-Cal plan approved her referral to a specialist, but it took her numerous phone calls, multiple complaints, and several months to book an appointment.
New HIV infections occur disproportionately among Black women, but exclusionary marketing, fewer treatment options, and provider wariness have limited uptake of preexposure prophylaxis, or PrEP, drugs, which reduce the risk of contracting the virus.
Congress is beginning to take action on the Social Security Administration’s clawbacks of payments it mistakenly made to poor, retired, and disabled Americans.
Pharmaceutical patents can drive up the costs of lifesaving medications. Hear what author and YouTube star John Green is doing to make tuberculosis drugs more accessible to the people who need them most.
In a torrent of lawsuits, patients accuse Florida device maker Exactech of hiding knee and hip implant defects for years. The company denies the allegations.
Trust is hard to build and easy to break. In Episode 6 of the “Eradicating Smallpox” podcast, meet Chandrakant Pandav, a health worker who used laughter and song to try to rebuild trust with communities harmed by India’s sometimes violent and coercive family planning campaign.
After seals in Seattle’s Puget Sound tested positive for H5N1 avian flu in late August, a researcher at the University of Washington Medical School is highlighting the unprecedented wave of cases in the last year and what that means for human health.
Forty percent of healthcare leaders are “not confident at all” that the U.S. would be better prepared for a future pandemic, according to a September Becker’s LinkedIn poll.